InvestorsHub Logo
Followers 13
Posts 697
Boards Moderated 0
Alias Born 01/12/2013

Re: betelgeuse post# 79452

Friday, 07/26/2013 7:49:54 AM

Friday, July 26, 2013 7:49:54 AM

Post# of 130507
Great post!! Good due diligence on your part. However, I feel its highly speculative to assume BD will partner (for some reason I am not believing your quote below is Geralds exact words....just dont think a CEO would be that straightforward and speculate to that extent). I am long and strong...so I hope it happens (but I want to keep things in check with reality too).

Quote:
AMBS feels that there is no reason why BD would not want to pay AMBS for in-licensing LymPro for the CLIA study and the subsequent commercialization. A first-ever Alzheimer blood biomarker would be a great asset for any company to have under their belt.